In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 38, Issue 2, Pages 258-265
Publisher
Wiley
Online
2017-07-18
DOI
10.1111/liv.13519
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice
- (2016) L. I. Backus et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens
- (2016) Zobair M Younossi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot study
- (2016) Zobair M. Younossi et al. BMC GASTROENTEROLOGY
- Effects of Viral Eradication With Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients With Chronic Hepatitis C Virus Infection
- (2016) Lynn Gerber et al. Clinical Gastroenterology and Hepatology
- Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden
- (2016) Zobair Younossi et al. GASTROENTEROLOGY
- Real-world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment-naive, genotype 1 hepatitis C-infected patients
- (2016) Lisa I. Backus et al. HEPATOLOGY
- Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trial
- (2016) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Patient-Reported Outcomes of Elderly Adults with Chronic Hepatitis C Treated with Interferon- and Ribavirin-Free Regimens
- (2016) Zobair M. Younossi et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network
- (2016) Z. M. Younossi et al. JOURNAL OF VIRAL HEPATITIS
- Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus
- (2016) Z. M. Younossi et al. JOURNAL OF VIRAL HEPATITIS
- Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus
- (2016) Z. M. Younossi et al. JOURNAL OF VIRAL HEPATITIS
- The value of cure associated with treating treatment-naïve chronic hepatitis C genotype 1: Are the new all-oral regimens good value to society?
- (2016) Zobair M. Younossi et al. LIVER INTERNATIONAL
- Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States
- (2016) Zobair M. Younossi et al. MEDICINE
- Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir
- (2016) Zobair M. Younossi et al. MEDICINE
- Mental and Emotional Impairment in Patients With Hepatitis C is Related to Lower Work Productivity
- (2016) Issah Younossi et al. PSYCHOSOMATICS
- Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection
- (2015) Z. M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life
- (2015) Z. M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: patient-reported outcomes in chronic hepatitis C - the impact of liver disease and new treatment regimens
- (2015) Z. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus
- (2015) Fujie Xu et al. CLINICAL INFECTIOUS DISEASES
- Trends in Burden of Cirrhosis and Hepatocellular Carcinoma by Underlying Liver Disease in US Veterans, 2001–2013
- (2015) Lauren A. Beste et al. GASTROENTEROLOGY
- Epidemiology of Hepatitis C Virus
- (2015) Norah J. Shire et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials
- (2015) Zobair M. Younossi et al. HEPATOLOGY
- Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: The Chronic Hepatitis Cohort Study (CHeCS)
- (2015) Joseph A. Boscarino et al. HEPATOLOGY
- Self-Efficacy and Adherence to Antiviral Treatment for Chronic Hepatitis C
- (2015) Jason E. Bonner et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir
- (2015) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes
- (2015) Zobair M. Younossi et al. JOURNAL OF INFECTIOUS DISEASES
- Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries
- (2015) Z. Younossi et al. JOURNAL OF VIRAL HEPATITIS
- A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection
- (2015) H. Park et al. JOURNAL OF VIRAL HEPATITIS
- The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study
- (2015) Zobair M. Younossi et al. LIVER INTERNATIONAL
- Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
- (2015) Michael P. Curry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
- (2015) Graham R. Foster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
- (2015) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment
- (2015) Brian P. Lam et al. Therapeutic Advances in Gastroenterology
- The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C
- (2014) Zobair Younossi et al. DIGESTIVE AND LIVER DISEASE
- Extrahepatic manifestations of chronic hepatitis C virus infection
- (2014) Patrice Cacoub et al. DIGESTIVE AND LIVER DISEASE
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir (Sovaldi) for the treatment of hepatitis C
- (2014) Brian Lam et al. Expert Review of Clinical Pharmacology
- The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings
- (2013) David B. Rein et al. ANNALS OF INTERNAL MEDICINE
- The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States
- (2013) Phil McEwan et al. HEPATOLOGY
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C
- (2013) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States
- (2013) Shan Liu et al. PLoS One
- The Cost-Effectiveness of Birth Cohort Screening for Hepatitis C Antibody in US Primary Care Settings
- (2012) Raj Vuppalanchi et al. GASTROENTEROLOGY
- Economic model of a birth cohort screening program for hepatitis C virus
- (2011) Lisa J. McGarry et al. HEPATOLOGY
- Hepatitis C Virus Genotypes in Clinical Specimens Tested at a National Reference Testing Laboratory in the United States
- (2011) J. J. Germer et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Insurance status and treatment candidacy of hepatitis C patients: Analysis of population-based data from the United States
- (2010) Maria Stepanova et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now